Morning SPAC News Roundup: February 26, 2025

At the SPAC of Dawn  The biotech sector has represented a significant portion of SPAC dealflow over the past five years, but signs are showing that it may take some previously unanticipated hits from the transition to the new US administration. Ginkgo Bioworks (NYSE:DNA) struck one of 2021’s headline deals at a $15 billion valuation
Read More